StockDrifts LogoStockDrifts

Ildong Pharmaceutical 249420

Company
일동제약Ildong Pharmaceutical
Insiders
3
Buys
5
Total Value
₩39M ($27K)
Avg Return
+89.80%
Last Filing
2026-04-02

Ildong Pharmaceutical (249420) has 5 disclosed insider purchases and 0 disclosed disposals on record, filed by 3 distinct insiders. Together those filings cover ₩39M ($27K) in reported transaction value. The earliest filing StockDrifts holds for Ildong Pharmaceutical is dated 2024-03-22; the most recent is 2026-04-02. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +89.80%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-04-02BUYMarket Buy
조노제
jonoje
Managing Director30₩27,000+4.7%₩810K ($563)
2026-04-01BUYMarket Buy
조노제
jonoje
Managing Director50₩29,350-3.7%₩1M ($1K)
2026-03-31BUYMarket Buy
조노제
jonoje
Managing Director50₩28,050+0.8%₩1M ($974)
2025-07-01BUY신규선임
서승욱
Seo Seung-wook
Managing Director605₩12,660+200.9%₩8M ($5K)
2025-02-24BUYMarket Buy
최규환
Gyu-hwan Choi
Internal director1.0K₩11,800+222.9%₩12M ($8K)
2024-12-24BUYMarket Buy
이승현
Seunghyun Lee
Managing Director2.0K₩11,750+224.3%₩24M ($16K)
2024-03-22BUY신규보고
최규환
Gyu-hwan Choi
Internal director5.0K₩16,870+125.8%₩84M ($59K)

Frequently asked questions

Who has been buying Ildong Pharmaceutical stock?
3 distinct insiders have filed 5 disclosed insider purchases in Ildong Pharmaceutical (249420), most recently on 2026-04-02. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Ildong Pharmaceutical have?
Ildong Pharmaceutical has 5 buy-side and 0 sell-side disclosures on record, covering ₩39M ($27K) in total reported value, spanning 2024-03-22 to 2026-04-02.
Where does StockDrifts get Ildong Pharmaceutical insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Ildong Pharmaceutical. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.